Serum levels of vasoactive factors in HIV-infected pre-eclamptic women on HAART

References

• Bhandari S, Raja EA, Shetty A, Bhattacharya S. 2014. Maternal and perinatal consequences of antepartum haemorrhage of unknown origin. BJOG: An International Journal of Obstetrics & Gynaecology 121:44–50.
   PubMed Web of Science ®Google Scholar
• Carbillon L. 2006. Uterine artery Doppler and changes in endothelial function before clinical disease in preeclamptic women. Hypertension 47:e16–e16.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, et al. 2013. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128:2121–2131.
   PubMed Web of Science ®Google Scholar
• Colasanti M, Suzuki H. 2000. The dual personality of NO. Trends in Pharmacological Sciences 21:249–252.
   PubMed Web of Science ®Google Scholar
• Echeverri I, Ortega-Ávila JG, Mosquera M, Castillo A, Jiménez E, Suárez-Ortegon MF, et al. 2015. Relationship between maternal and newborn endothelial function and oxidative stress. American Journal of Human Biology 27:822–831.
   PubMed Web of Science ®Google Scholar
• Ellis J, Williams H, Graves W, Lindsay MK. 2002. Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. American Journal of Obstetrics and Gynecology 186:903–906.
   PubMed Web of Science ®Google Scholar
• Foidart J-M, Schaaps J-P, Chantraine F, Munaut C, Lorquet S. 2009. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia—a step forward but not the definitive answer. Journal of Reproductive Immunology 82:106–111.
   PubMed Web of Science ®Google Scholar
• Gilbert JS, Gilbert SA, Arany M, Granger JP. 2009. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53:399–403.
   PubMed Web of Science ®Google Scholar
• Govender N, Naicker T, Rajakumar A, Moodley J. 2013. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 170:100–105.
   PubMed Web of Science ®Google Scholar
• Granger JP, Alexander BT, Bennett WA, Khalil RA. 2001. Pathophysiology of pregnancy-induced hypertension. American Journal of Hypertension 14:S178–185S.
   PubMed Web of Science ®Google Scholar
• Haffejee F, Naicker T, Singh M, Moodley J. 2013. Placental leptin in HIV-associated preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 171:271–276.
   PubMed Web of Science ®Google Scholar
• Herraiz I, Llurba E, Verlohren S, Galindo A, on behalf of the Spanish Group for the Study of Angiogenic Markers in Preeclampsia. 2018. Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/PlGF ratio in singleton pregnancies. Fetal Diagnosis and Therapy 43:81–89.
   PubMed Web of Science ®Google Scholar
• Kalumba VMS, Moodley J, Naidoo TD. 2013. Is the prevalence of pre-eclampsia affected by HIV/AIDS? A retrospective case–control study. Cardiovascular Journal of Africa 24:24–27.
   PubMed Web of Science ®Google Scholar
• Lam C, Lim K-H, Karumanchi SA. 2005. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46:1077–1085.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, Yu KF, et al. 2004. Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine 350:672–683.
   PubMed Web of Science ®Google Scholar
• Lu YP, Hasan AA, Zeng S, Hocher B. 2017. Plasma ET-1 concentrations are elevated in pregnant women with hypertension – meta-analysis of clinical studies. Kidney and Blood Pressure Research 42:654–663.
   PubMed Web of Science ®Google Scholar
• Martin F, Taylor G. 2009. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is ‘the more the merrier’? Journal of Antimicrobial Chemotherapy 64:895–900.
   PubMed Web of Science ®Google Scholar
• Mattar R, Amed AM, Lindsey PC, Sass N, Daher S. 2004. Preeclampsia and HIV infection. European Journal of Obstetrics & Gynecology and Reproductive Biology 117:240–241.
   PubMed Web of Science ®Google Scholar
• Moodley J, Pattinson RC, Fawcus S, Schoon M, Moran N, Shweni P, National Committee on Confidential Enquiries into Maternal Deaths in South Africa. 2014. The confidential enquiry into maternal deaths in South Africa: a case study. BJOG: An International Journal of Obstetrics & Gynaecology 121:53–60.
   PubMed Web of Science ®Google Scholar
• Murphy SR, Lamarca BB, Cockrell K, Granger JP. 2010. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 55:394–398.
   PubMed Web of Science ®Google Scholar
• Napolitano M, Miceli F, Calce A, Vacca A, Gulino A, Apa R, Lanzone A. 2000. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. The Journal of Clinical Endocrinology & Metabolism 85:2318–2323.
   PubMed Web of Science ®Google Scholar
• Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. 1991. Maternal plasma level of endothelin is increased in preeclampsia. American Journal of Obstetrics and Gynecology 165:724–727.
   PubMed Web of Science ®Google Scholar
• Oujo B, Perez-Barriocanal F, Bernabeu C, Lopez-Novoa JM. 2013. Membrane and soluble forms of endoglin in preeclampsia. Current Molecular Medicine 13:1345–1357.
   PubMed Web of Science ®Google Scholar
• Parikh RV, Scherzer R, Grunfeld C, Nitta EM, Leone A, Martin JN, et al. 2013. Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals. Atherosclerosis 229:246–252.
   PubMed Web of Science ®Google Scholar
• Possomato-Vieira JS, Khalil RA. 2016. Mechanisms of endothelial dysfunction in hypertensive pregnancy and preeclampsia. Advances in Pharmacology 77:361–431.
   PubMedGoogle Scholar
• Powis KM, McElrath TF, Hughes MD, Ogwu A, Souda S, Datwyler SA, et al. 2013. High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among Women Initiating highly active antiretroviral therapy (HAART) in pregnancy in the Mma Bana Study, Botswana. Journal of Acquired Immune Deficiency Syndromes (1999) 62:517–524.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. 1999. Preeclampsia: an excessive maternal inflammatory response to pregnancy. American Journal of Obstetrics and Gynecology 180:499–506.
   PubMed Web of Science ®Google Scholar
• Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ. 1999. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre‐eclampsia. BJOG: An International Journal of Obstetrics and Gynaecology 106:1019–1022.
   Web of Science ®Google Scholar
• Roberts JM, Von Versen-Hoeynck F. 2007. Maternal fetal/placental interactions and abnormal pregnancy outcomes. Hypertension 49:15–16.
   PubMed Web of Science ®Google Scholar
• Saleh L, Verdonk K, Visser W, Van Den Meiracker AH, Danser AH. 2016. The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia. Therapeutic Advances in Cardiovascular Disease 10:282–293.
   PubMedGoogle Scholar
• Sánchez-Aranguren LC, Prada CE, Riaño-Medina CE, Lopez M. 2014. Endothelial dysfunction and preeclampsia: role of oxidative stress. Frontiers in Physiology 5:372.
   PubMed Web of Science ®Google Scholar
• Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. 2014. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health 2:e323–e333.
   PubMed Web of Science ®Google Scholar
• Shah DA, Khalil RA. 2015. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochemical Pharmacology 95:211–226.
   PubMed Web of Science ®Google Scholar
• Sibiude J, Guibourdenche J, Dionne M-D, Le Ray C, Anselem O, Serreau R, et al. 2012. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One 7:e50208.
   PubMed Web of Science ®Google Scholar
• Smith-Jackson K, Hentschke M, Poli-De-Figueiredo C, Da Costa BP, Kurlak L, Pipkin FB, et al. 2015. Placental expression of eNOS, iNOS and the major protein components of caveolae in women with pre-eclampsia. Placenta 36:607–610.
   PubMed Web of Science ®Google Scholar
• Stratton P, Tuomala RE, Abboud R, Rodriguez E, Rich K, Pitt J, et al. 1999. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 20:179–186.
   PubMedGoogle Scholar
• Suy A, Martínez E, Coll O, Lonca M, Palacio M, De Lazzari E, et al. 2006. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 20:59–66.
   PubMed Web of Science ®Google Scholar
• Taylor RN, Varma M, Teng NN, Roberts JM. 1990. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. The Journal of Clinical Endocrinology & Metabolism 71:1675–1677.
   PubMed Web of Science ®Google Scholar
• Vata PK, Chauhan NM, Nallathambi A, Hussein F. 2015. Assessment of prevalence of preeclampsia from Dilla region of Ethiopia. BMC Research Notes 8:816.
   PubMedGoogle Scholar
• Wimalasundera R, Larbalestier N, Smith J, De Ruiter A, Thom SM, Hughes A, et al. 2002. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. The Lancet 360:1152–1154.
   PubMed Web of Science ®Google Scholar
• Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, Lutalo T, et al. 2013. Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). The Lancet 381:1763–1771.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Li M, Chen Y, Wang S. 2015. Homocysteine, endothelin-1 and nitric oxide in patients with hypertensive disorders complicating pregnancy. International Journal of Clinical and Experimental Pathology 8:15275–15279.
   PubMed Web of Science ®Google Scholar